Diagnosis of erectile dysfunction (ED) requires anamnestic investigation, being rarely spontaneously declared by patients. ED occurs frequently in diabetes mellitus, and anecdotal evidence suggests that ED occurs in obesity and in hypothyroidism. The aim of this study was to evaluate the prevalence of ED in patients affected by thyroid disorders (hypothyroidism and hyperthyroidism), in comparison with control subjects and with patients at risk for ED, such as patients with obesity and with type II diabetes mellitus, and the role of age. Spontaneous deposition and International Index of Erectile Dysfunction (IIEF)-5 questionnaire were considered for control subjects and for all patients. Spontaneous deposition of ED occurred for three diabetic patients, never for obese patients, thyroid patients and controls, confirming the value of IIEF-5 in detecting ED. ED was more frequent in obese subjects (42%), and in patients affected by thyroid diseases (59%), than in controls (30%), although less frequent than in type II diabetes mellitus (81%). Both below and above the age of 50 years, ED score was worse in thyroid patients than in control subjects, while ED was more frequent in obese patients than in control subjects only below the age of 50 years.
Introduction
Erectile dysfunction (ED) is defined as the inability to achieve and maintain an erection sufficient to permit satisfactory sexual intercourse. 1 ED may be related to age, [2] [3] [4] [5] [6] [7] to a series of systemic diseases such as diabetes mellitus, atherosclerosis, cardiac ischemic disease, arterial hypertension, 5, [8] [9] [10] [11] [12] central and autonomic neuropathy, kidney and liver failure, anxiety and depression, or may be determined by drugs, surgical intervention and traumatisms, alcoholism and tabagism. 13 The prevalence of ED in diabetic patients has been exhaustively investigated and has been reported to be from 25 to 75%. [14] [15] [16] [17] [18] In Italy in a 2.8 years follow-up study, the incidence was 68 new cases/1000 patients/year towards 25.9 new cases/1000 patients/years found in the general population. 12, 19 Fewer data are available about the relationship between ED and endocrine diseases. Androgen deficiency decreases nocturnal erections and libido, 20 and hyperprolactinemia causes ED.
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Obesity is also associated with high risk of ED. 22 Up to date, there are no epidemiological data on ED in thyroid diseases, even though anecdotal evidence suggests a possible link between hypothyroidism and ED. 23, 24 Diagnosis of ED requires an accurate anamnestic investigation, being rarely spontaneously declared by patients, and is usually detected through ad hoc questionnaires (as the International Index of Erectile Dysfunction, IIEF-5); 25 IIEF-5 also allows categorization of the degree of ED. 7 The aim of this study was to evaluate the prevalence of ED in patients affected by thyroid disorders (hypothyroidism and hyperthyroidism) in comparison with control subjects and with patients at risk for ED, such as patients with obesity and with diabetes mellitus, and the role of age; to do so, spontaneous deposition and a IIEF-5 questionnaire were considered for control subjects and for all patients.
Materials and methods
The protocol of the study was approved by the local Ethics Committee. For each group of patients, who were on a regular follow-up, spontaneous deposition of ED was recorded during outpatient visits, that is, during history collection. Then, an IIEF-5 25 was administered to all subjects accepting to do so. After completion of the questionnaire, ED was scored as follows: no ED for score above 20; mild ED for score [16] [17] [18] [19] [20] ; moderate ED for score 11-15; and severe ED for score 10 and less. 7 Controls were from the medical staff and the administrative staff of Ospedale San Paolo, in good health, and free from medications for any current medical condition. Table 1 shows the clinical and metabolic details investigated for each group of subjects, the mean value and the relevant limits observed.
Calculations and statistical analysis ED degrees were expressed as absolute frequencies, and compared among all groups and subgroups by w 2 test. Age was expressed as mean7s.e. Subjects and controls were subdivided according to age into two groups (o50 and 450 years). Pairwise regression analysis was performed between continuous variables and ED score. To further characterize the independent contribution of age and kind of disease, a multiple regression analysis was performed with variables statistically significant at univariate regression, plus age and kind of disease.
Results
Spontaneous deposition of ED occurred for three diabetic patients, never for obese patients, thyroid patients and controls. Therefore, the value of IIEF-5 was highly significant for both controls and obese patients, thyroid patients and diabetic patients ( Figure 1 ). Figure 1 also shows that ED score (all ages) was better in controls than in thyroid patients and in diabetic patients, in obese patients than in diabetic patients and in thyroid patients than in diabetic patients, with no other significant differences. Figure 2a shows that in the age group 23-50 years, ED score was worse in obese patients than in Prevalence of ED in patients with thyroid disorders A Veronelli et al controls, and better than in thyroid patients; in addition, ED score was worse in thyroid patients and in diabetic patients than in controls. It can be concluded that in this age group, obese patients are particularly at risk of ED. Figure 2b shows that in the age group 51-80 years, ED score was significantly better in controls than in thyroid patients and in diabetic patients; thyroid patients and obese patients also differed from diabetic patients. Table 2 shows that both kinds of thyroid disease (hypothyroidism and hyperthyroidism) are accompanied by a significant difference of ED score as compared to controls. ED score was not associated, in diabetic patients, with the kind of treatment, and metabolic control (not shown); similarly, in thyroid patients, ED score was not associated with duration of thyroid disease, presence of thyroid antibodies, TSH levels, kind of treatment and other medical conditions (not shown). In controls and in diabetic patients, age (o50 vs 450 years) was associated with worsening of ED score, not in obese patients or in thyroid patients; at multiple regression analysis, ED score was associated with the presence of thyroid disease, obesity and diabetes mellitus (F ¼ 62.44), and with age of patients (F ¼ 7.74).
Discussion
Our data confirm that the use of an IIEF-5 questionnaire 24 allows detection of ED in a significant proportion of control subjects as well as of diabetic patients, obese patients and patients with thyroid disorders; without the use of a questionnaire, the great majority of these subjects would not spontaneously declare ED. Our data show that ED is a frequent finding in patients affected by thyroid diseases, be it patients with hypothyroidism or hyperthyroidism. The prevalence is, however, in general lower than in diabetic patients. The nature of the association between thyroid disorders and ED is a matter of speculation, as we found no association between ED and kind of disease, duration of disease, presence or absence of thyroid antibodies, kind of treatment and TSH levels. Therefore, we cannot put forward any interpretation, and we cannot exclude a mere psychological reason, justified by concern of patients for their own thyroid disease. Of interest is also the fact that aging was not associated, in these patients, with a significant worsening of ED score, indicating that thyroid problems are more important than the aging process in determining the appearance of ED. One limit to this study is that it was cross-sectional, and therefore prospective studies are required to assess the effect of diseases themselves and of substitution therapy in hypothyroid patients as well as the effect of thionamides and of other drugs in hyperthyroid patients.
In diabetic patients, we found a high prevalence of ED; this agrees with previous data indicating that diabetes mellitus carries a very high risk of ED. [12] [13] [14] [15] [16] [17] [18] [19] However, probably due to the small sample size of our diabetic patients, all with type II diabetes, we could find no relationship between ED, HbA1 c levels, presence of complications, treatment with oral agents or with insulin, although ED score worsened with age, while it is known, from larger studies, that ED is more frequent in patients with longer duration of diabetes, and with poor metabolic control. 12, 19, 26 Obesity, as already reported, 22 is frequently associated with ED; it has to be underlined, however, that ED was mainly of mild degree, and this Prevalence of ED in control subjects and in patients with obesity, thyroid disorders, and diabetes mellitus (mild, moderate and severe ED) according to age (a: age o50 years; b: age 450 years). Subjects without ED are not shown. 
Comparisons are between patients of all ages (in parentheses between patients of the two age groups Prevalence of ED in patients with thyroid disorders A Veronelli et al has never been reported so far; an additional novel finding is that ED appears quite early in life, as before the age of 50 years, it carries a high risk of ED, higher than in control subjects, although lower than in thyroid patients. The reason for this early appearance of ED is a matter for conjecture; we would only like to remember that obesity, similar to diabetes, is characterized by endothelial dysfunction, 27 a basic mechanism for ED. 9, 10 Recently, it was shown that weight loss is accompanied by an improvement of endothelial dysfunction, and by improvement of ED. 28 In conclusion, this paper emphasizes the utility of structured interviews for detection of ED in normal subjects and in various kinds of patients, confirming the frequent occurrence of ED in diabetic and obese patients, and indicates that ED is a frequent finding in patients with thyroid disorders. Further research is required to understand the nature of the link between thyroid disorders and ED, for instance, by looking at endothelial function in thyroid disorders.
